Transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR) is a minimally invasive cardiac procedure for patients with aortic valve stenosis who are not eligible for open-heart surgery. This FDA-approved treatment repairs the abnormally narrow aortic valve without removing the damaged valve.

• Faster recovery
• Minimal scarring
• Reduced hospital stays
• Lower risk of complications

• You have symptoms caused by aortic stenosis.
• You are not a candidate for surgical aortic valve replacement or you’re at high risk for surgery.

• Damage to your blood vessels
• Bleeding
• Decreased blood supply to your brain, causing a stroke
• Heart attack
• Kidney failure
• Collection of fluid around your heart
• Leaking of the replacement valve